Dinko Berkovic

1.9k total citations · 1 hit paper
28 papers, 1.6k citations indexed

About

Dinko Berkovic is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Dinko Berkovic has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Dinko Berkovic's work include Protein Kinase Regulation and GTPase Signaling (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Organophosphorus compounds synthesis (4 papers). Dinko Berkovic is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Organophosphorus compounds synthesis (4 papers). Dinko Berkovic collaborates with scholars based in Germany and Estonia. Dinko Berkovic's co-authors include Stefan Schütze, Martin Krönke, Karin Potthoff, Katja Wiegmann, Thomas Machleidt, Clemens Unger, E. A. M. Fleer, Claudia R. Binder, Lutz Binder and Lorenz Trümper and has published in prestigious journals such as Cell, The Journal of Experimental Medicine and Clinical Infectious Diseases.

In The Last Decade

Dinko Berkovic

27 papers receiving 1.6k citations

Hit Papers

TNF activates NF-κB by phosphatidylcholine-specific phosp... 1992 2026 2003 2014 1992 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dinko Berkovic Germany 15 1.0k 397 240 223 201 28 1.6k
Claude Aussel France 25 920 0.9× 603 1.5× 179 0.7× 135 0.6× 181 0.9× 103 1.8k
Hai Le Trong United States 16 1.3k 1.2× 655 1.6× 287 1.2× 140 0.6× 193 1.0× 18 2.3k
Miriam Galvonas Jasiulionis Brazil 24 1.0k 1.0× 364 0.9× 337 1.4× 328 1.5× 156 0.8× 63 1.8k
Iwao Ohkubo Japan 26 874 0.8× 244 0.6× 423 1.8× 195 0.9× 160 0.8× 94 1.8k
Christopher L. Reading United States 19 731 0.7× 350 0.9× 338 1.4× 148 0.7× 121 0.6× 74 1.8k
Jeffrey D. Ceci United States 20 1.2k 1.2× 449 1.1× 289 1.2× 324 1.5× 136 0.7× 27 2.0k
Hirofumi Sawai Japan 17 1.5k 1.4× 303 0.8× 171 0.7× 164 0.7× 207 1.0× 40 1.8k
Rocco J. Rotello United States 11 1.1k 1.1× 497 1.3× 243 1.0× 157 0.7× 92 0.5× 13 1.7k
Masashi Morita Japan 21 1.6k 1.5× 334 0.8× 389 1.6× 214 1.0× 206 1.0× 89 2.1k
Jean‐Bernard Denault Canada 25 1.7k 1.7× 386 1.0× 341 1.4× 268 1.2× 167 0.8× 49 2.3k

Countries citing papers authored by Dinko Berkovic

Since Specialization
Citations

This map shows the geographic impact of Dinko Berkovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dinko Berkovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dinko Berkovic more than expected).

Fields of papers citing papers by Dinko Berkovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dinko Berkovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dinko Berkovic. The network helps show where Dinko Berkovic may publish in the future.

Co-authorship network of co-authors of Dinko Berkovic

This figure shows the co-authorship network connecting the top 25 collaborators of Dinko Berkovic. A scholar is included among the top collaborators of Dinko Berkovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dinko Berkovic. Dinko Berkovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berkovic, Dinko, E. A. M. Fleer, H. Eibl, & Clemens Unger. (2015). Effects of Hexadecylphosphocholine on Cellular Function. Progress in tumor research. 34. 59–68.
2.
Fleer, E. A. M., Dinko Berkovic, Clemens Unger, & H. Eibl. (2015). Cellular Uptake and Metabolic Fate of Hexadecylphosphocholine. Progress in tumor research. 34. 33–46. 3 indexed citations
3.
Binder, Lutz, et al.. (2006). Utility of Procalcitonin Concentration in the Evaluation of Patients with Malignant Diseases and Elevated C-Reactive Protein Plasma Concentrations. Clinical Infectious Diseases. 43(4). 468–473. 40 indexed citations
4.
Verbeek, Walter, et al.. (2004). Endoskopische Spaltung eines intraluminalen Duodenaldivertikels beim Erwachsenen wegen Oberbauchbeschwerden. Zeitschrift für Gastroenterologie. 42(12). 1377–1379. 1 indexed citations
5.
Berkovic, Dinko & Christian Hallermann. (2003). Carcinoma of the Pancreas with Neuroendocrine Differentiation and Nodular Panniculitis. Oncology Research and Treatment. 26(5). 473–476. 13 indexed citations
6.
Binder, Lutz, et al.. (2003). Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients?. Annals of Hematology. 82(2). 98–103. 38 indexed citations
7.
Berkovic, Dinko, et al.. (2002). Effects of hexadecylphosphocholine on phosphatidylcholine and phosphatidylserine metabolism in human lymphoma cells. PubMed. 2(2). 85–92. 8 indexed citations
8.
Berkovic, Dinko, et al.. (2002). Hexadecylphosphocholine does not influence phospholipase D and sphingomyelinase activity in human leukemia cells. PubMed. 2(4). 213–218. 7 indexed citations
9.
Berkovic, Dinko, J. Bertram, Timo Wille, et al.. (2001). Effects of hexadecylphosphocholine on thrombocytopoiesis. European Journal of Cancer. 37(4). 503–511. 8 indexed citations
10.
Berkovic, Dinko. (1998). Cytotoxic Etherphospholipid Analogues. General Pharmacology The Vascular System. 31(4). 511–517. 54 indexed citations
11.
Berkovic, Dinko, et al.. (1997). Expression of two 50 kDa proteins is associated with sensitivity towards etherlipid analogues in the human leukaemia cell line HL 60. European Journal of Cancer. 33(11). 1875–1880. 2 indexed citations
12.
Berkovic, Dinko, et al.. (1997). Differential regulation of phospholipase A2 in human leukemia cells by the etherphospholipid analogue hexadecylphosphocholine. Biochemical Pharmacology. 53(11). 1725–1733. 13 indexed citations
13.
Berkovic, Dinko, et al.. (1997). Synergistic cytotoxic effects of ether phospholipid analogues and ionizing radiation in human carcinoma cells. Radiotherapy and Oncology. 43(3). 293–301. 25 indexed citations
14.
Berkovic, Dinko, Dagmar Haase, W. Hiddemann, & E. A. M. Fleer. (1996). Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues.. PubMed. 1(6). 368–75. 11 indexed citations
15.
Fleer, E. A. M., et al.. (1996). Induction of resistance to hexadecylphosphocholine in the highly sensitive human epidermoid tumour cell line KB. European Journal of Cancer. 32(3). 506–511. 16 indexed citations
16.
Berkovic, Dinko, et al.. (1995). Effects of hexadecylphosphocholine on membrane phospholipid metabolism in human tumour cells. European Journal of Cancer. 31(12). 2080–2085. 24 indexed citations
17.
Rieder, Harald, Susanne Schnittger, H. Bodenstein, et al.. (1995). dic(9; 20): A new recurrent chromosome abnormality in adult acute lymphoblastic leukemia. Genes Chromosomes and Cancer. 13(1). 54–61. 34 indexed citations
18.
Schütze, Stefan, Karin Potthoff, Thomas Machleidt, et al.. (1992). TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced “Acidic” sphingomyelin breakdown. Cell. 71(5). 765–776. 949 indexed citations breakdown →
19.
Schütze, Stefan, et al.. (1991). Tumor necrosis factor induces rapid production of 1'2'diacylglycerol by a phosphatidylcholine-specific phospholipase C.. The Journal of Experimental Medicine. 174(5). 975–988. 169 indexed citations
20.
Berkovic, Dinko, et al.. (1990). Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells. Journal of Cancer Research and Clinical Oncology. 116(5). 459–466. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026